BostonGene: Funding, Investors & Team (Oct 2026)
BostonGene Corporation is pioneering the use of biomedical software for advanced patient analysis and personalized therapy decision making in the fight against cancer. BostonGene’s unique solution performs sophisticated analytics to aid clinicians in their evaluation of viable treatment options for each patient's individual genetics, tumor and tumor microenvironment, clinical characteristics and disease profile. BostonGene’s mission is to enable physicians to provide every patient with the highest probability of survival through optimal cancer treatments using advanced, personalized therapies
BostonGene has raised $150M across 1 funding round on record, the most recent a Series B of $150M announced in Apr 2022.
That round is above the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
BostonGene Company Profile and Key Stats
Latest funding round on record: Apr 2022.
BostonGene Funding Rounds
BostonGene Founders and Leadership Team
No contact details are on record for this team yet.
BostonGene Funding Compared to Other Biotechnology Startups
BostonGene's latest round of $150M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like BostonGene in Biotechnology and Waltham
Companies Similar to BostonGene
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
BostonGene Funding FAQs
What does BostonGene do?
BostonGene Corporation is pioneering the use of biomedical software for advanced patient analysis and personalized therapy decision making in the fight against cancer. BostonGene’s unique solution performs sophisticated analytics to aid clinicians in their evaluation of viable treatment options for each patient's individual genetics, tumor and tumor microenvironment, clinical characteristics and disease profile. BostonGene’s mission is to enable physicians to provide every patient with the highest probability of survival through optimal cancer treatments using advanced, personalized therapies
How much funding has BostonGene raised?
BostonGene has raised $150M across 1 round on record. The most recent is a Series B of $150M announced in Apr 2022.
When did BostonGene last raise funding?
BostonGene's most recent funding round on record is a Series B of $150M, announced in Apr 2022.
Who is the CEO of BostonGene?
Andrew Feinberg is listed as CEO at BostonGene.
Where is BostonGene headquartered?
BostonGene is based in Waltham, Massachusetts, United States.
How many employees does BostonGene have?
BostonGene is in the 101-250 employee band.
How does BostonGene's funding compare to other Biotechnology startups?
BostonGene's latest round of $150M is above the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's BostonGene Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for BostonGene is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.